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Abstract 
A rare case of giant intra and parasellar 
chordoma, mimicking a pituitary 
prolactinoma is presented. The tumor 
involving pituitary fossa and surrounding 
structures was removed via a bifrontal 
approach. The pathology exhibited the 
typical histological patterns of a chordoma. 
The authors present a rare case of a giant 
sellar and parasellar chordoma and review 
the literature on that. 
Keywords: chordoma, sella turcica, 
pituitary prolactinoma 
Introduction 
Chordomas represent 1% of all 
malignant bone tumors and 0.1 to 0.2% of 
intracranial neoplasms (6, 7). In Romania, 
the Pathology Department of the Bucharest 
Oncologic Institute has reported a low 
frequency for chordoma 0.12%. These 
embrionary tumors, first described by 
Luschka in 1856 are rare, slow-growing 
neoplasms with maligne potential, that arise 
from cell rests, particularly of the proximal 
and distal extremes of the notochord, 
characterized by osseous permeation, high 
local recurrence, local invasiveness (4-14). 
Their metastatic potential cannot be 
estimated by histological examination, 
except in cases of sarcomatous 
transformation (10). The most common 
site are: 50% in the sacrococcygeal region – 
mean age 50 years, especially to men, 35% 
in the base of skull - in the midline, 
especially to childs or young adults; 15% in 
vertebrae (7). Large, intra et parasellar 
chordomas resembling a pituitary 
prolactinoma are rare (12).  
Case presentation 
A 64 year old woman, without 
pathological antecedents, was admitted in 
our department for headache, progressive 
decrease of visual acuity of right eye, double 
vision instaled over the past 2 months. On 
general and neurological examination we 
found decrease of visual acuity of right eye: 
VOD = 2/3 without corection, VOS = 1, 
the external rotation of the right eyeball was 
not possible, visual field examination 
disclosed bitemporal hemianopsia; fundus 
oculi: plane, well contured papila, with 
tortous and dilated veins, thin arteries, 
macula without reflex on right eye; the light 
reflex of both pupils in direct & indirect 
responses was normal. No endocrinopathy 
was noted but serum pituitary hormone 
levels revelead high prolactin levels: 84 
ng/ml, reference value 2.5–17, less basal 
cortisolemia 1,24 μg/dl, reference value 5–
25, betachorionic gonadotropin (hCG), 
alpha-fetoprotein (FP) and 
carcinoembryonic antigen (CEA) were 
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normal; diabetes insipidus investigation also 
was normal. 
Radiography of the skull revealed 
enlargement and distortion of the sella, 
with osteolysis of its floor and invasion of 
the sphenoid bone. A high-resolution CT 
scan revealed a large, partly calcified 
intrasellar tumor, showing suprasellar 
extension and erosion of the sphenoid 
bone. 
Cerebral MRI  (Figure 1) demonstrated 
a sellar area tumor measured 28/32/34 mm, 
in its greatest diameter, with hypersignal in 
T1 and T2-weighted images, omogenous, 
with slight inside calcifications, polycyclic 
outlined. This tumor is elevating the 
pituitary gland and optic chiasm, posterior 
overpass clivus, is in contact with the 
basilary artery and on the right side invaded 
the latero-selar compartment, without 
affecting the carotid artery. Therefore the 
carotid arteriography was normal. 
A bifrontal microscopic approach was 
performed; a yellow encapsulated, soft with 
necrotic center tumor was discovered, 
extended intra, supra and right parasellar. 
The tumor was removed, the latero-selar 
compartment too, the optic chiasm was 
decompressed as like as the pituitary stalk, 
less a small part of the tumor with tight 
adhesion to the pituitary stalk. 
Microcalcifications in the suprasellar and 
sellar portions were detected. Postoperatory 
evolution was uneventfull confirmed by 
cerebral CT (Figure 2) and at 6-months 
follow-up examination after radiotherapy, 
the patient was asymptomatic, serum 
pituitary hormone levels revelead normal 
levels. 
Histologic and immunohistochemistry 
tests are indicative for a tumoral chordoma. 
Patolology diagnosis was made on 
macroscopic criteria: lobulated fragments, 
tan-to-red, of various dimensions, soft 
consistency, sometimes kistic, diffuse 
borders, invading adiacent structures. 
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Figure 1 Cerebral MRI studies: axial (A), coronal 
(B) and sagittal (C) revealing a large mass occupying 
the pituitary fossa, elevating the pituitary gland and 
optic chiasm, and invading the right cavernous sinus 
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Figure 2 Postoperatory CT-scan 1 month after 
operation 
 
On section tumor is gelatinous, 
translucide with green with red-brune 
areas. Microscopic criteria (Figure 3): 
lobular pattern, more important in central 
part of the tumor, with different shapes, 
fibrous septa of variable thickness, more 
important at the tumor periphery, 
containing vessels.The arterial supply in the 
central area were very small, but necrosis 
was very offen encountred. Smaller lobuli, 
perhaps younger, disposed at the peryphery, 
contain oval, polygonal or prismatic cells, 
mimiking a carcinomatous aspect. This cells 
has important cytoplasma, omogenous, 
with small vacuolar areas containing 
glicogen and progressive tendency to 
coalescence. The nuclei are small, spheric – 
rarely with reniform shape, disposed central 
with prominent nucleoli. In the cells with 
multiple vacuolar areas, nuclei has the 
tendency to picnosis.  
In medium or big lobuli the proliferative 
cells were disposed circumferential and 
extended to the centrum part of the lobuli 
with a radial structure. In the central area, 
intracytoplasmatic vacuoles develop in 
volume and number; by vacuoles 
coalescence cells has the tendency to 
become “physaliphorous cells” with small 
nuclei disposed central or in the periphery 
(physaliphorous comes  from the  greek  
word physalis = bubble). Gigant, 
multinucleated cells are rare. Cytoplasmic 
vacuoles were smaller than those in the 
intercellular matrix. Another microscopic 
criteria was represented by an important 
mucoid stroma with glycogenic component 
(see the period-acid-Schiff method), where 
cells arranged in lobules are embedded. 
Very rare cells has pseudo-glandular aspects 
with limphocytes at the periphery, partial 
limitated by a capsula made by conjunctive 
tissue.  
Immunocytochemical analysis of the 
chordoma cells showed focal positivity for 
vimentin, EMA. Negative 
immunoreactivity for CEA was noted. 
Ultrastructurally, the tumor was composed 
of large cells containing irregular nuclei 
with multiple indentations and prominent 
nucleoli. Analysis of DNA revealed a 
diploid histogram. 
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Figure 3 Chordoma: microscopic criteria and details for immunohistochemistry 
(A) chordoma HE - Ob.10 X: tumoral lobes, different shapes, sepparated by fibrotic septs,  
(B) detail:  chordoma HE - Ob. 20 X: as vacuoles are bigger, the cells limit are estompated, (C) another detail 
of chordoma HE - Ob. 20 X, (D) VIM positive IHC coloration - Ob.10 X, (E) detail of VIM positive IHC 
coloration - Ob. 20 X, (F) PAS present as a marker of glicogen in mucilaginous substance expelled in 
extracells space - Ob. 20 X, (G) detail of MNF  (myelinated nerve fibres) 116 positive diffuse – Ob. 20 X,  
(H) detail of EMA (epithelial membrane antigen) positive diffuse – Ob. 20 X, (I)  LEU 7 – zonnal positive - 
Ob. 20 X, (J)  CEA (carcinoembryonic antigen) negative - Ob. 40 X 
 
Discussion 
Chordomas involving the sellar region 
are extremely rare, more frequent in 
younger patients - second to fifth decades 
of life, with a a male/female ratio of 6: 5 (5, 
7) Most chordomas involving the sellar 
region depending on anatomical location 
and clinical features could be devided in 
three groups (12): parasellar or suprasellar 
chordomas with optic tract compression 
and oculomotor nerve palsy; largely or 
entirely sellar chordomas – are very rare, 
mimicking pituitary adenoma with chiasm 
compression and hypopituitarism, clival 
chordomas with brainstem compression 
and bilateral sixth cranial nerve paresis. 
Several studies according to Thoudou et al. 
(12) has pointed the misdiagnosed 
preoperatively as pytuitary adenoma, 
craniopharingioma based on clinical 
symptoms (visual deficit as the most 
common symptom, hyperprolactinemia or 
hypopituitarism more commonly observed 
in the sellar and suprasellar chordomas) and 
radiologic findings (bone distruction 
involving pituitary fossa, petrous bone, 
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orbit, foramen ovale, jugular foramen and 
even foramen magnum; calcifications in the 
tumoral mass or sequestrated bone 
fragment) The skull base chordomas tend 
to present osseous permeation, and have a 
high rate of recurrence (4-7, 10, 14, 15). 
Their metastatic potential cannot be 
estimated by histological examination, 
except in cases of sarcomatous 
transformation (1-3, 6, 8, 10). 
The imaging method of choice are MRI, 
also CT – scan with contrast and thin slices 
for reconstructions (7). A sellar chordoma 
CT scan may reveal a contrast-enhancing 
intrasellar mass with bony erosions and 
calcifications well demonstrated in bone 
window images (11, 15). 
In general surgery should be complete, 
the capsular tumoral adhesions to chiasma 
or another nervous structure made this 
purpose sometimes impossible and 
postoperative irradiation are recommended 
despite inconclusive data (7, 10, 12).  
The immunohistologic profile of 
chordoma cells is reactivity to cytokeratins, 
vimentin, and epithelial membrane (1-3, 7, 
9). The only known prognostic study 
published in 1993 estimated overall survival 
rates of 51% and 35% at 10 and 20 years, 
respectively (6). Differential diagnosis 
should be made with other large sellar and 
suprasellar tumor mass as pituitary 
adenomas, especially if a calcified intrasellar 
tumor with bone erosion is diagnosed; 
chondroid chordoma, chondrosarcoma 
with mucoid intercellular substance 
containing calcifications (5, 7, 14).   
Conclusion 
Chordomas are midline slow-growing 
tumors that arise from proximal and distal 
extreme remnants of the notochord, are 
locally invasive, may metastasize and are 
characterized by local recurrence. These 
tumor can mimick a pituitary adenomas, 
especially if a calcified intrasellar tumor 
with bone erosion is diagnosed. A gross-
total resection followed by radiotherapy, has 
been the accepted treatment for sellar 
chordomas. 
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